PSRC1 Regulated by DNA Methylation Is a Novel Target for LGG Immunotherapy
In conclusion, this study identified the pathogenic role ofPSRC1 in the pathological progression of LGG, expanding the molecular understanding ofPSRC1, and provided a biomarker and potential immunotherapeutic target for the treatment of LGG.
Source: Journal of Molecular Neuroscience - Category: Neuroscience Source Type: research
More News: Brain | Brain Tumor | Cancer | Cancer & Oncology | Databases & Libraries | Genetics | Glioma | Immunotherapy | Neurology | Neuroscience | Study